CancerLinQ Earns ASCO RQS for Automated Oncology Quality Tracking

CancerLinQ SmartLinQ options save time, enabling practitioners to concentrate on offering care with seamless participation in ASCO’s flagship high quality program, ASCO Licensed

ConcertAI, a pacesetter in oncology generative and agentic AI SaaS and multi-modal knowledge (MMD) options for healthcare and life sciences, in the present day introduced its initiative, CancerLinQ®, is now a acknowledged high quality resolution for medical high quality measures knowledge for ASCO Licensed. As an ASCO Acknowledged High quality Answer (RQS) supplier, CancerLinQ automates high quality monitoring for ASCO Licensed practices, saving medical groups a median of 4-20 hours every week (relying on the apply dimension) from handbook abstraction, redirecting time for affected person care. ASCO RQS allows CancerLinQ’s oncology practices to extra simply submit high quality measure knowledge for ASCO Licensed—making a frictionless expertise for well being system and oncology apply companions. Reaching this recognition demonstrates CancerLinQ’s dedication to knowledge integrity, supporting oncology apply companions and bettering affected person care.

A Dedication to Information High quality

ASCO RQS identifies know-how and knowledge suppliers that supply high quality knowledge merchandise and assets to oncology practices. By means of this recognition, oncology practices have a dependable and straightforward approach to adjust to ASCO Licensed knowledge necessities. As a newly acknowledged ASCO RQS supplier, CancerLinQ can submit medical high quality measures knowledge on behalf of oncology practices taking part in ASCO Licensed—ASCO’s flagship high quality program that certifies outpatient oncology practices and well being techniques to satisfy complete requirements for patient-centered care. This system additionally serves as a next-generation high quality measurements initiative, enabling oncology practices to overview high quality, outcomes and utilization measures from digital well being information, insurance coverage claims, affected person satisfaction surveys and evidence-based remedy pathways. With its newly acquired standing, CancerLinQ serves as a gateway to this complete program for companions to attain ASCO Licensed standing.

Higher Monitoring and Extra Time for Affected person Care

The automation replaces handbook abstraction usually carried out by directors, high quality managers, clinicians, or nurses, releasing up time and assets for affected person care. Not like conventional high quality audits that overview solely pattern circumstances, CancerLinQ’s automation supplies complete monitoring throughout all eligible sufferers, enabling end-to-end evaluation of care high quality. This system additionally affords inside and exterior benchmarking capabilities, permitting practices to check their efficiency in opposition to comparable websites and establish particular care gaps that want enchancment.

With out this automation, practices face both handbook chart abstraction that captures solely pattern sufferers or no high quality measurement in any respect. This complete monitoring empowers ASCO Licensed accomplice websites to show worth to sufferers, insurance coverage corporations and different stakeholders whereas sustaining competitiveness via measurable high quality outcomes.

“Oncologists knew they supplied a very excessive stage of high quality care, however they didn’t have the time to manually measure it in full,” mentioned Dr. Robert S. Miller, chief medical science officer at CancerLinQ. “We’ve given them one much less factor to fret about, so they’ll have extra time to concentrate on offering the absolute best care to their sufferers.”

Changing into an RQS Information Supplier

CancerLinQ underwent a rigorous validation course of that reviewed crucial knowledge components for medical high quality measurement and demonstrated a dedication to knowledge high quality. CancerLinQ leverages real-world knowledge from over 9 million sufferers to ship actionable insights and standardized high quality measures that establish and shut care gaps, whereas supporting medical trial screening and evidence-based remedy plans that enhance affected person outcomes and promote effectivity.

“This recognition is one other stellar step in ConcertAI’s decade-long collaboration with ASCO and our dedication to supporting the CancerLinQ neighborhood with dependable, high-quality knowledge options,” mentioned Eron Kelly, CEO of ConcertAI. “Being an RQS supplier positions us to assist extra practices ship evidence-based, patient-centered care whereas harnessing the ability of AI to drive higher outcomes.”

To use to develop into an ASCO RQS knowledge supplier and to obtain assets, contact [email protected] [Attn: Recognized Quality Solution]. For oncology practices and most cancers facilities excited about becoming a member of the rising CancerLinQ community, contact [email protected].

The submit CancerLinQ Earns ASCO RQS for Automated Oncology Quality Tracking first appeared on AI-Tech Park.